: Zoetis raised 2021 adj. EPS outlook to $4.47-$4.55 from $4.42-$4.51

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Zoetis Inc.

Zoetis, Inc. discovers, develops, and manufactures a portfolio of animal health medicines and vaccines. The firm operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices, and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply